Literature DB >> 4163361

Nuclear fluorescence employing antinucleoside immunoglobulins.

W J Klein, S M Beiser, B F Erlanger.   

Abstract

Fluoresceinated antinucleoside globulins were shown to react with the nuclei of L cells. The pattern of nuclear fluorescence was similar to the distribution of nuclear DNA. This reaction was shown to be specific by the following control experiments: 1. Absorption of the specific antibody from an antiadenosine globulin eliminated all fluorescence. 2. Treatment of the cells with nonfluorescent antiadenosine globulin, followed by staining with the fluorescent antiadenosine eliminated almost all of the fluorescence of the nucleus. 3. Treatment of the cells with DNase destroyed the ability of the nucleus to react with antiuridine fluorescent antibodies. 4. Fluoresceinated anti-BSA did not produce nuclear fluorescence. Nuclear fluorescence occurred only in cells harvested during the period of maximum DNA synthesis as measured by the uptake of thymidine. This correlates with the previously demonstrated specificity of the antibodies for denatured DNA.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4163361      PMCID: PMC2138338          DOI: 10.1084/jem.125.1.61

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  Variations in the morphological patterns of "autoimmune" nuclear fluorescence.

Authors:  J S BECK
Journal:  Lancet       Date:  1961-06-03       Impact factor: 79.321

3.  Gamma globulin and complement in the diseased kidney.

Authors:  P FREEDMAN; A S MARKOWITZ
Journal:  J Clin Invest       Date:  1962-02       Impact factor: 14.808

4.  Correlation of antinuclear antibodies and nuclear staining patterns.

Authors:  P J LACHMANN; H G KUNKEL
Journal:  Lancet       Date:  1961-08-19       Impact factor: 79.321

5.  The L.E. cell phenomenon.

Authors:  H R HOLMAN
Journal:  Annu Rev Med       Date:  1960       Impact factor: 13.739

6.  Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein.

Authors:  H R HOLMAN; H G KUNKEL
Journal:  Science       Date:  1957-07-26       Impact factor: 47.728

7.  Identification of the nuclear component of the interaction of lupus erythematosus globulin and nuclei.

Authors:  G J FRIOU
Journal:  J Immunol       Date:  1958-06       Impact factor: 5.422

8.  Studies on antinuclear antibodies.

Authors:  M Seligmann; A Cannat; M Hamard
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

9.  Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.

Authors:  E M Tan; H G Kunkel
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

10.  Antinuclear antibodies in rabbit antisera.

Authors:  E V Barnett; J H Vaughan
Journal:  J Exp Med       Date:  1966-04-01       Impact factor: 14.307

View more
  4 in total

1.  Occurrence of antibodies to single-stranded DNA in ANA negative patients.

Authors:  C A Wasicek; P J Maddison; M Reichlin
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

2.  Chromosome structure as revealed by a combined chemical and immunochemical procedure.

Authors:  R R Schreck; D Warburton; O J Miller; S M Beiser; B F Erlanger
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

3.  Immunofluorescent patterns and specificity of human antinuclear antibodies.

Authors:  Y B Bickel; E V Barnett; C M Pearson
Journal:  Clin Exp Immunol       Date:  1968-09       Impact factor: 4.330

4.  Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.

Authors:  G A Andres; L Accinni; S M Beiser; C L Christian; G A Cinotti; B F Erlanger; K C Hsu; B C Seegal
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.